Smith & Nephew plc
NYSE:SNNMedical - Devices
-$0.43 today
- Market cap
- $12.72B
- Beta
- 0.67
- P/E (TTM)
- 20.1
- EPS (TTM)
- $0.74
- Dividend yield
- 2.59%
Volume 1.22M
Average 1.10M
SNN Net Income
Bottom-line profit after all expenses, interest, and taxes.
Smith & Nephew plcNYSE: SNN
Net Income · Q4 FY2025 · quarter ended Dec 2025
Net income grows 67.7% year over year
Q4 FY2025 net income of $332M rose 67.7% year over year. Over 3 fiscal years it compounded at +41.0% a year.
Context
- Net income amounted to 10.1% of revenue in FY2025, up 3.0 pp from a year earlier.
- Net income increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 7 analysts of $931.84M (+49.1%) for the fiscal year ending Dec 2026, a slowdown from the +51.7% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterDec 2025
- $332M— QoQ
- Last fiscal yearDec 2025
- $625M+51.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +67.7% | — | — |
| 1 year | +51.7% | +49.1% | -2.6 pp |
| 3-year CAGR | +41.0% | +21.4% | -19.6 pp |
| 5-year CAGR | +16.1% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the income statement
- Latest · FY2025
- 625M USD
- Year-over-year change
- +51.7%
- 4-year CAGR
- +4.5%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 625M | +51.7% |
| FY2024 | 2024-12-31 | 412M | +56.7% |
| FY2023 | 2023-12-31 | 263M | +17.9% |
| FY2022 | 2022-12-31 | 223M | -57.4% |
| FY2021 | 2021-12-31 | 524M | — |
Net Income vs competitors
How SNN compares with its peers on the latest reported figures
- SNN's FY2025 net income of $625M is the 3rd highest of the 11 companies compared; the peer median is -$18.93M.
- Its year-over-year change of +51.7% is the 3rd highest of 11, against a peer median of +13.4%.
- Net income amounts to 10.1% of revenue for SNN, versus a peer median of 15.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $3.73B | +27.8% | +11.2% | 14.4% | |
| LTM Jun 2026 | $806.8M | -2.0% | +45.0% | 9.5% | |
| FY2025 | $625M | +51.7% | +41.0% | 10.1% | |
| LTM Jun 2026 | $535.46M | +50.1% | +41.4% | 17.0% | |
| LTM Mar 2026 | $54.85M | -53.8% | — | 4.0% | |
| LTM Mar 2026 | $1.83M | +115.2% | — | 1.5% | |
| LTM Mar 2026 | -$39.68M | +2.5% | — | 16.3% | |
| LTM Mar 2026 | -$60.01M | +58.1% | — | 7.3% | |
| LTM Mar 2026 | -$125.36M | +24.3% | — | 15.9% | |
| LTM Mar 2026 | -$495.8M | -1612.3% | — | 30.1% | |
| LTM Apr 2026 | -$1.14B | -40.5% | — | 49.9% | |
| Peer median (excluding SNN) | -$18.93M | +13.4% | +41.4% | 15.2% | |
Competitors are the stored peer set for SNN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 5.21B | 5.22B | 5.55B | 5.81B | 6.16B |
| Cost of Revenue | 1.51B | 1.52B | 1.65B | 1.73B | 1.96B |
| Gross Profit | 3.7B | 3.7B | 3.9B | 4.08B | 4.21B |
| Gross Margin | 71.0% | 70.9% | 70.2% | 70.2% | 68.3% |
| Research & Development | 356M | 345M | 339M | 343M | 346M |
| Selling, General & Admin | 2.64B | 2.71B | 2.83B | 2.9B | 3.04B |
| Operating Expenses | 3.11B | 3.25B | 3.47B | 3.42B | 3.41B |
| Depreciation & Amortization | 507M | 492M | 473M | 449M | 459M |
| EBITDA | 1.22B | 1.15B | 1.21B | 1.34B | 1.34B |
| EBITDA Margin | 23.4% | 22.1% | 21.9% | 23.0% | 21.7% |
| Operating Income | 593M | 450M | 425M | 657M | 794M |
| Operating Margin | 11.4% | 8.6% | 7.7% | 11.3% | 12.9% |
| Interest Income | 6M | 13.99M | 34.13M | 24.01M | 28.07M |
| Interest Expense | 79.99M | 79.95M | 132.51M | 150.06M | 141.33M |
| Other Income / Expenses | (7M) | (215M) | (135M) | (159M) | (15M) |
| Income Before Tax | 586M | 235M | 290M | 498M | 779M |
| Pre-Tax Margin | 11.2% | 4.5% | 5.2% | 8.6% | 12.6% |
| Income Tax Expense | 62M | 12M | 27M | 86M | 154M |
| Net Income | 524M | 223M | 263M | 412M | 625M |
| Net Margin | 10.1% | 4.3% | 4.7% | 7.1% | 10.1% |
| EPS (Basic) | 1.20 | 0.50 | 1.20 | 0.94 | 1.46 |
| EPS (Diluted) | 1.20 | 0.50 | 1.20 | 0.94 | 1.44 |
| Weighted Avg Shares | 438.5M | 437.55M | 217.75M | 438.3M | 433.42M |
| Weighted Avg Shares (Diluted) | 438.86M | 437.55M | 218.44M | 438.3M | 436.47M |
Smith & Nephew plc
NYSE:SNN
Intrinsic Alpha fair value
Locked
Current Price
$30.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.